HSD3B1 Expression Is Upregulated by Interleukin 4 in HT-29 Colon Cancer Cells via Multiple Signaling Pathways

Area of Science:

• Endocrinology
• Molecular Biology
• Cancer Research

Background:

• 3β-Hydroxysteroid dehydrogenase/isomerase (HSD3B1) is critical for active steroid hormone synthesis.
• Interleukin 4 (IL4) is known to induce HSD3B1 expression in cancer cell lines.

Purpose of the Study:

• To investigate the molecular mechanisms by which IL4 induces HSD3B1 expression in HT-29 colon cancer cells.
• To elucidate the role of IL4-induced HSD3B1 in steroid hormone synthesis.

Main Methods:

• Administered IL4 to HT-29 colon cancer cells.
• Analyzed HSD3B1 mRNA and protein levels.
• Investigated the involvement of STAT6, PI3-kinase/AKT, and MAPK pathways using inhibitors and assessing protein activity/phosphorylation.
• Measured steroid synthesis.

Main Results:

• IL4 significantly increased HSD3B1 mRNA and protein expression in HT-29 cells.
• IL4 activated STAT6, which bound to the HSD3B1 promoter, and STAT6 inhibition suppressed HSD3B1 induction.
• Inhibition of PI3-kinase/AKT pathways suppressed IL4-induced HSD3B1 expression, while GSK3 activity potentiated it at later stages.
• MAPK pathway components ERK1/2 and p38 partially reduced HSD3B1 expression.
• IL4 treatment potently promoted steroid synthesis.

Conclusions:

• IL4 induces HSD3B1 expression in HT-29 colon cancer cells through multiple signaling pathways, including STAT6, PI3K/AKT, and MAPKs.
• IL4-mediated HSD3B1 induction plays a role in regulating steroid hormone synthesis.